Literature DB >> 32788699

A dendritic cell multitasks to tackle cancer.

Marianne Burbage, Sebastian Amigorena.   

Abstract

Entities:  

Keywords:  Cancer; Immunology

Mesh：

Year:  2020        PMID： 32788699     DOI： 10.1038/d41586-020-02339-9

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  11 in total

1.  Spatiotemporally Distinct Interactions with Dendritic Cell Subsets Facilitates CD4+ and CD8+ T Cell Activation to Localized Viral Infection.

Authors:  Jyh Liang Hor; Paul G Whitney; Ali Zaid; Andrew G Brooks; William R Heath; Scott N Mueller
Journal:  Immunity       Date:  2015-08-18       Impact factor: 31.745

2.  Differential antigen processing by dendritic cell subsets in vivo.

Authors:  Diana Dudziak; Alice O Kamphorst; Gordon F Heidkamp; Veit R Buchholz; Christine Trumpfheller; Sayuri Yamazaki; Cheolho Cheong; Kang Liu; Han-Woong Lee; Chae Gyu Park; Ralph M Steinman; Michel C Nussenzweig
Journal:  Science       Date:  2007-01-05       Impact factor: 47.728

Review 3.  Dendritic cells in cancer immunology and immunotherapy.

Authors:  Stefanie K Wculek; Francisco J Cueto; Adriana M Mujal; Ignacio Melero; Matthew F Krummel; David Sancho
Journal:  Nat Rev Immunol       Date:  2019-08-29       Impact factor: 53.106

4.  Robust Anti-viral Immunity Requires Multiple Distinct T Cell-Dendritic Cell Interactions.

Authors:  Sarah Eickhoff; Anna Brewitz; Michael Y Gerner; Frederick Klauschen; Karl Komander; Hiroaki Hemmi; Natalio Garbi; Tsuneyasu Kaisho; Ronald Nathan Germain; Wolfgang Kastenmüller
Journal:  Cell       Date:  2015-08-18       Impact factor: 41.582

5.  Human CD1c+ dendritic cells secrete high levels of IL-12 and potently prime cytotoxic T-cell responses.

Authors:  Giulia Nizzoli; Jana Krietsch; Anja Weick; Svenja Steinfelder; Federica Facciotti; Paola Gruarin; Annalisa Bianco; Bodo Steckel; Monica Moro; Mariacristina Crosti; Chiara Romagnani; Katharina Stölzel; Sara Torretta; Lorenzo Pignataro; Carmen Scheibenbogen; Petra Neddermann; Raffaele De Francesco; Sergio Abrignani; Jens Geginat
Journal:  Blood       Date:  2013-06-21       Impact factor: 22.113

Review 6.  Cross-Presentation in Mouse and Human Dendritic Cells.

Authors:  Elodie Segura; Sebastian Amigorena
Journal:  Adv Immunol       Date:  2015-04-08       Impact factor: 3.543

7.  Transcriptional programming of dendritic cells for enhanced MHC class II antigen presentation.

Authors:  Bryan Vander Lugt; Aly A Khan; Jason A Hackney; Smita Agrawal; Justin Lesch; Meijuan Zhou; Wyne P Lee; Summer Park; Min Xu; Jason DeVoss; Chauncey J Spooner; Cecile Chalouni; Lelia Delamarre; Ira Mellman; Harinder Singh
Journal:  Nat Immunol       Date:  2013-12-22       Impact factor: 25.606

Review 8.  Dendritic cells, monocytes and macrophages: a unified nomenclature based on ontogeny.

Authors:  Martin Guilliams; Florent Ginhoux; Claudia Jakubzick; Shalin H Naik; Nobuyuki Onai; Barbara U Schraml; Elodie Segura; Roxane Tussiwand; Simon Yona
Journal:  Nat Rev Immunol       Date:  2014-07-18       Impact factor: 53.106

9.  Adjustment of dendritic cells to the breast-cancer microenvironment is subset specific.

Authors:  Paula Michea; Floriane Noël; Eve Zakine; Urszula Czerwinska; Philémon Sirven; Omar Abouzid; Christel Goudot; Alix Scholer-Dahirel; Anne Vincent-Salomon; Fabien Reyal; Sebastian Amigorena; Maude Guillot-Delost; Elodie Segura; Vassili Soumelis
Journal:  Nat Immunol       Date:  2018-07-16       Impact factor: 25.606

10.  Human lymphoid organ cDC2 and macrophages play complementary roles in T follicular helper responses.

Authors:  Mélanie Durand; Thomas Walter; Tiphène Pirnay; Thomas Naessens; Paul Gueguen; Christel Goudot; Sonia Lameiras; Qing Chang; Nafiseh Talaei; Olga Ornatsky; Tatiana Vassilevskaia; Sylvain Baulande; Sebastian Amigorena; Elodie Segura
Journal:  J Exp Med       Date:  2019-05-09       Impact factor: 14.307
View more
  7 in total

1.  Generation of αGal-enhanced bifunctional tumor vaccine.

Authors:  Jian He; Yu Huo; Zhikun Zhang; Yiqun Luo; Xiuli Liu; Qiaoying Chen; Pan Wu; Wei Shi; Tao Wu; Chao Tang; Huixue Wang; Lan Li; Xiyu Liu; Yong Huang; Yongxiang Zhao; Lu Gan; Bing Wang; Liping Zhong
Journal:  Acta Pharm Sin B       Date:  2022-03-09       Impact factor: 14.903

Review 2.  The Role of Long Non-Coding RNAs in the Tumor Immune Microenvironment.

Authors:  Yingli Guo; Yajuan Xie; Yao Luo
Journal:  Front Immunol       Date:  2022-02-09       Impact factor: 7.561

Review 3.  Understanding the functional inflammatory factors involved in therapeutic response to immune checkpoint inhibitors for pan-cancer.

Authors:  Yanmeizhi Wu; Shan Yu; Hong Qiao
Journal:  Front Pharmacol       Date:  2022-09-01       Impact factor: 5.988

Review 4.  The role of DNA damage repair (DDR) system in response to immune checkpoint inhibitor (ICI) therapy.

Authors:  Congqi Shi; Kaiyu Qin; Anqi Lin; Aimin Jiang; Quan Cheng; Zaoqu Liu; Jian Zhang; Peng Luo
Journal:  J Exp Clin Cancer Res       Date:  2022-09-07

Review 5.  Targeting the extracellular matrix for immunomodulation: applications in drug delivery and cell therapies.

Authors:  Samira Aghlara-Fotovat; Amanda Nash; Boram Kim; Robert Krencik; Omid Veiseh
Journal:  Drug Deliv Transl Res       Date:  2021-06-26       Impact factor: 4.617

Review 6.  Overcoming biological barriers to improve solid tumor immunotherapy.

Authors:  Anvay Ukidve; Katharina Cu; Ninad Kumbhojkar; Joerg Lahann; Samir Mitragotri
Journal:  Drug Deliv Transl Res       Date:  2021-02-20       Impact factor: 4.617

Review 7.  DCision-making in tumors governs T cell anti-tumor immunity.

Authors:  Francesca Alfei; Ping-Chih Ho; Wan-Lin Lo
Journal:  Oncogene       Date:  2021-07-21       Impact factor: 9.867
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.